Which Benefits are Mentioned Most Often in Drug Development Publications?

Conclusions Both theoretically expected and actually reported benefits in the majority of the included publications emphasized the importance of individual patient benefits from drug development rather than the collective benefits to society in general. The authors of these publications emphasized the right of each individual patient/subject to look for and expect some personal benefit from participating in a clinical trial; rather than considering societal benefit as a top priority [2]. From an ethical point of view, however, the benefits each individual patient received from their participation in a clinical trial might also be seen as a societal benefit, especially when the drug or device tested, if approved for marketing, would eventually be made available for other similar patients from the country in which the clinical trial was conducted [3].
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research